The trial’s primary endpoint is the change in gout pain intensity from baseline in the target joint at day three.

Purified Cortrophin Gel is the only ACTH therapy approved by the FDA for the treatment of acute gout flares Trial to be ...

PRINCETON, N.J., May 27, 2025 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced that Nikhil Lalwani, Chief Executive Officer, will present at the 2025 ...

ANI Pharmaceuticals (NASDAQ:ANIP) is gearing up to announce its quarterly earnings on Friday, 2025-05-09. Here's a quick overview of what investors should know before the release. Analysts are ...

ANI Pharmaceuticals Inc. is a Baudette, Minnesota-based biopharmaceutical concern focused on the development, manufacture, and marketing of branded and generic drugs primarily in the U.S. The ...

ANI Pharmaceuticals (NASDAQ:ANIP) has been analyzed by 5 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish. The table below summarizes their ...